UNIGE document Scientific Article
previous document  unige:135512  next document
add to browser collection
Title

Allogeneic stem cell transplantation for blast crisis chronic myeloid leukemia in the era of tyrosine kinase inhibitors: a retrospective study by the EBMT chronic malignancies working party

Authors
Radujkovic, Aleksandar
Dietrich, Sascha
Blok, Henric-Jan
Nagler, Arnon
Ayuk, Francis
Finke, Jürgen
Tischer, Johanna
Mayer, Jiri
show hidden authors show all authors [1 - 26]
Published in Biology of Blood and Marrow Transplantation. 2019, vol. 25, no. 10, p. 2008-2016
Abstract The prognosis of patients with blast crisis (BC) chronic myeloid leukemia (CML) is still dismal. Allogeneic stem cell transplantation represents the only curative treatment option, but data on transplant outcomes are scarce. We therefore conducted a retrospective, registry-based study of adult patients allografted for BC CML, focusing on patients with active disease at transplant and pretransplant prognostic factors. One hundred seventy patients allografted for BC CML after tyrosine kinase inhibitor pretreatment between 2004 and 2016 were analyzed. Before transplant, 95 patients were in remission, whereas 75 patients had active BC. In multivariable analysis of the entire cohort, active BC at transplant was the strongest factor associated with decreased overall survival (hazrd ratio, 1.87; P = .010) and shorter leukemia-free survival (LFS; hazard ratio, 1.69; P = .017). For patients with BC in remission at transplant, advanced age (≥45 years), lower performance status (≤80%), longer interval from diagnosis BC to transplant (>12 months), myeloablative conditioning, and unrelated donor (UD) transplant were risk factors for inferior survival. In patients with active BC, only UD transplant was significantly associated with prolonged LFS and trended toward improved overall survival. In summary, survival of patients allografted for BC CML was strongly dependent on pretransplant remission status. In patients with remission of BC, conventional prognostic factors remained the major determinants of outcome, whereas in those with active BC at transplant, UD transplant was associated with prolonged LFS in our study.
Keywords Allogeneic stem cell transplantationBlast crisisChronic myeloid leukemiaOutcomeTyrosine kinase inhibitor.
Identifiers
PMID: 31271884
Full text
Article (Published version) (563 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Supplemental data (20 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research group Leucémie et transplantation allogénique de cellules souches hématopoïétiques (982)
Citation
(ISO format)
RADUJKOVIC, Aleksandar et al. Allogeneic stem cell transplantation for blast crisis chronic myeloid leukemia in the era of tyrosine kinase inhibitors: a retrospective study by the EBMT chronic malignancies working party. In: Biology of Blood and Marrow Transplantation, 2019, vol. 25, n° 10, p. 2008-2016. doi: 10.1016/j.bbmt.2019.06.028 https://archive-ouverte.unige.ch/unige:135512

64 hits

0 download

Update

Deposited on : 2020-05-03

Export document
Format :
Citation style :